F605 in Tennessee. Pick another state for the same tag.
Against expectation — 2025
Tennessee cites F605 less often than its own record predicts
Versus expected share0.49×
0.49 times the national share — cited less often here than elsewhere.
Share of Tennessee citations0.35%
Of every deficiency written in Tennessee in 2025, this is the portion that was F605.
Tennessee0.35%
National0.70%
Share of all citations that were F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Tennessee surveyors wrote
F605 findings written in Tennessee, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedFebruary 12, 2026
Based on facility policy review, medical record review, and interview the facility failed to provide a rationale for the continued use of an as needed (PRN) antianxiety medication beyond 14 days for 1 resident (Resident #19) of 5 residents reviewed for unnecessary medications. The findings include: Review of the facility's undated policy titled, Psychotropic Medication Use Guidelines, revealed .PRN orders all psychotropic drugs shall be used only when the medication is necessary to treat a diagnosed specific condition that is documented in the clinical record, and for a limited duration (i.e. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction